Arkolith/Insider Trading/CRNX/Form 4

Vivaldi Coelho Rogerio

DirectorCrinetics Pharmaceuticals, Inc. (CRNX) · full profile →Form 4 · filed Mar 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$181K
Net Open-Market Flow
-$181K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 12, 2026Sell(S)4K$36.08$162K17K
Mar 12, 2026Sell(S)523$36.77$19K16K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-017797) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML